2011
DOI: 10.1590/s1984-82502011000400028
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and in vitro evaluation of taste-masked oro-dispersible dosage form of diltiazem hydrochloride

Abstract: Diltiazem hydrochloride is a calcium channel blocker generally indicated for the treatment of angina and hypertension, and it is extensively metabolized due to the hepatic metabolism. Formulation of diltiazem hydrochloride into an oro-dispersible dosage form can provide fast relief with higher bioavailability. The bitter taste of the drug should be masked to formulate it in a palatable form. In the present work, an attempt was made to mask the taste by complexation technique, with a formulation into an oro-dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 18 publications
0
14
0
Order By: Relevance
“…However, because of the speed of interaction, merely having the cyclodextrin in the formulation had the same effects as pre-forming the complex. In a similar approach, cyclodextrins were used to reduce the bitterness of diltiazem hydrochloride (58) and cetirizine (59) in orodispersible tablets.…”
Section: Delivery Systems To Mask Bitter Tastementioning
confidence: 99%
“…However, because of the speed of interaction, merely having the cyclodextrin in the formulation had the same effects as pre-forming the complex. In a similar approach, cyclodextrins were used to reduce the bitterness of diltiazem hydrochloride (58) and cetirizine (59) in orodispersible tablets.…”
Section: Delivery Systems To Mask Bitter Tastementioning
confidence: 99%
“…The most effective approach is the addition of sweeteners and flavors combined with physical taste masking that prevents the interaction of the drug substance with taste buds . However, only incorporation of taste‐masked APIs into ODTs prepared by direct compression has been reported up to now . Different methodologies have been used to achieve proper taste masking of APIs, including spray drying with Eudragit® E, coating with hydroxypropylcellulose or Eudragit® RL30‐D, and granulation or extrusion with different excipients and polymers .…”
Section: Introductionmentioning
confidence: 99%
“…22,23 However, only incorporation of taste-masked APIs into ODTs prepared by direct compression has been reported up to now. [23][24][25][26][27][28][29][30] Different methodologies have been used to achieve proper taste masking of APIs, including spray drying with Eudragit R E, 29,30 coating with hydroxypropylcellulose 28 or Eudragit R RL30-D, 24 and granulation or extrusion with different excipients and polymers. 23,26,27 However, these taste masking methods result in particles or granules that have to be incorporated into the tablet matrix.…”
Section: Introductionmentioning
confidence: 99%
“…The resulting mixture was stirred for 1 hour and evaporated at a temperature of 45 °C until dried. The dried mass was pulverized and sieved through sieve no.20 [10] The ternary complex comprising of 0.25% w/v (HPMC E5) was prepared by first dissolving required amounts of β-cyclodextrin and polymer in distilled water which was then added to the methanolic solution of carbamazepine [9]and then the same procedure was done like that for the binary system.…”
Section: Second-solvent Evaporation Methods For Preparation Of the Commentioning
confidence: 99%
“…Experiment for the ternary system was performed analogously to those for the binary systems, but in the presence of 0.25% w/v HPMC E5 [9] After 48 h mixing, the samples were filtered through a millipore filter paper 0.45 μm., the concentration of the dissolved carbamazepine was determined spectrophotometrically at 284 nm.…”
Section: First-phase Solubility Studiesmentioning
confidence: 99%